Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Involvement of N-Methyl-D-Aspartate Receptors in the Antidepressant-Like Effect of 5-Hydroxytryptamine 3 Antagonists in Mouse Forced Swimming Test and Tail Suspension Test Publisher Pubmed



Kordjazy N1, 2 ; Hajmirzaian A1, 2 ; Amiri S1, 2 ; Ostadhadi S1, 2 ; Aminikhoei H1, 2 ; Dehpour AR1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Experimental Medicine Research Center, Tehran University of Medical Sciences, P.O. Box 13145-784, Tehran, Iran
  2. 2. Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, P.O. Box 13145-784, Tehran, Iran

Source: Pharmacology Biochemistry and Behavior Published:2016


Abstract

Recent evidence indicates that 5-hydroxytryptamine 3 (5-HT3) antagonists such as ondansetron and tropisetron exert positive behavioral effects in animal models of depression. Due to the ionotropic nature of 5-HT3 and N-methyl-d-aspartate (NMDA) receptors, plus their contribution to the pathophysiology of depression, we investigated the possible role of NMDA receptors in the antidepressant-like effect of 5-HT3 receptor antagonists in male mice. In order to evaluate the animals' behavior in response to different treatments, we performed open-field test (OFT), forced swimming test (FST), and tail-suspension test (TST), which are considered as valid tasks for measuring locomotor activity and depressive-like behaviors in mice. Our data revealed that intraperitoneal (i.p.) administration of tropisetron (5, 10, and 30 mg/kg) and ondansetron (0.01, and 0.1 μg/kg) significantly decreased the immobility time in FST and TST. Also, co-administration of subeffective doses of tropisetron (1 mg/kg, i.p.) or ondansetron (0.001 μg/kg, i.p.) with subeffective doses of NMDA receptor antagonists, ketamine (1 mg/kg, i.p.), MK-801 (0.05 mg/kg, i.p.) and magnesium sulfate (10 mg/kg, i.p.) resulted in a reduced immobility time both in FST and TST. The subeffective dose of NMDA (NMDA receptor agonist, 75 mg/kg, i.p.) abolished the effects of 5-HT3 antagonists in FST and TST, further supporting the presumed interaction between 5-HT3 and NMDA receptors. These treatments did not affect the locomotor behavior of animals in OFT. Finally, the results of our study suggest that the positive effects of 5-HT3 antagonists on the coping behavior of mice in FST and TST are at least partly mediated through NMDA receptors participation. © 2015 Published by Elsevier Inc.
Experts (# of related papers)
Other Related Docs
47. Behavioral Despair Associated With a Mouse Model of Crohn's Disease: Role of Nitric Oxide Pathway, Progress in Neuro-Psychopharmacology and Biological Psychiatry (2016)